A carregar...
BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma
Although much progress has been made in the treatment of multiple myeloma, the majority of patients fail to be cured and require numerous lines of therapy. Inhibitors of the BCL2 family represent an exciting new class of drugs with a novel mechanism of action that are likely to have activity as sing...
Na minha lista:
| Publicado no: | Blood Lymphat Cancer |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7965688/ https://ncbi.nlm.nih.gov/pubmed/33737856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S245191 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|